Targeted next-generation sequencing (NGS) of carcinoma of unknown primary site (CUP): Actionable genomic alterations (GA) and new routes to targeted therapies.

Jeffrey S Ross,Vincent A Miller,Deborah Morosini,Doron Lipson,Phil Stephens,Juliann Chmielecki,Gary A Palmer,Roman Yelensky,Siraj M Ali,Geoff Otto,Kai Wang

doi:10.1200/jco.2014.32.15_suppl.11048

Targeted next-generation sequencing (NGS) of carcinoma of unknown primary site (CUP): Actionable genomic alterations (GA) and new routes to targeted therapies.

Jeffrey S Ross, Vincent A Miller + Show 9 more

https://doi.org/10.1200/jco.2014.32.15_suppl.11048

Copy DOI

Journal: Journal of Clinical Oncology	Publication Date: May 20, 2014
Citations: 1

Affiliation: Albany Medical Center Hospital

#Carcinoma Of Unknown Primary Site #Actionable Genomic Alterations + Show 7 more

Abstract
Full-Text PDF
Similar Papers

Abstract

11048 Background: CUP comprises 3% of adult malignancy in the US. Evaluation for a primary site is often unrevealing and may involve invasive studies. We performed NGS to identify potential therape...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Clinical Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.